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Normal and Pathologic Biochemistry
of the Lung
by Aron B. Fisher*
The lung is an important metabolic organ. Glucose provides the major source of substrate. Ox-
idative pathways are active and are required to maintain normal tissue energy stores. Synthetic ac-
tivity in the lung is extensive and related mainly to synthesis of dipalmitoyl lecithin and other
components of the lung surfactant system. The lung plays an important role in the metabolism of
xenobiotics and endogenous hormones leading to degradation as well as activation of important
biologic properties.
Only recently has the lung been recognized as
an important metabolic organ rather than just a
tissue for passive gas exchange. A major reason
for the delay in appreciation of the metabolic role
of the lung is related to its structure and ana-
tomic relationships. The lung, although filling
most of the thoracic cavity, actually comprises
only 1% of the body weight, and approximately
30% ofthat weight is due to contained blood. Fur-
ther, the blood flow to the lung comprises the en-
tire cardiac output making it the most richly per-
fused organ in the body. Because of the high
blood flow in relation to metabolizing tissue mass,
arteriovenous differences of most metabolites
cannot be measured across the lung in situ. Con-
sequently, it has been necessary to develop in
vitro models for study of lung metabolism. One
model that has been extensively used is the iso-
lated perfused lung preparation. Perfusion of the
lung with artificial media removes the red cells
from the pulmonary capillaries and results in
tissue with a completely white appearance. Addi-
tional models to study lung metabolism are tissue
slices and preparations of subcellular organelles.
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By use of these preparations, it has been possible
to gain insights into lung metabolism, although
our understanding is still far from complete. This
paper will be a superficial survey of activity in
this new field and will focus specifically on oxy-
gen utilization and energy generation, lung sur-
factant and metabolism, and metabolism of hor-
mones and xenobiotics.
Oxygen Uptake
Measurements with the isolated perfused lung
preparation or lung slices have shown oxygen up-
take in the range of 30-150 jA/min-g dry weight,
depending on species and preparation (1). There-
fore, lung tissue has significant 02 consumption
although values are low compared with the me-
tabolically very active organs. For example,
dog lung oxygen uptake per unit weight is only
10-20% of the oxygen uptake of canine heart,
kidney, thyroid, and brain (1). The oxygen uptake
of the lung is greater, however, than that of
resting skeletal muscle, intestine, and many
other metabolically less active tissues. Actually,
the lung can be considered an average organ in
terms of 02 utilization, since its oxygen uptake
represents approximately 1% of the total oxygen
August 1976 3uptake ofthe organism, and this is approximately
the contribution of the lung to total body weight.
On the other hand, it should be noted that the
lung represents a heterogeneous collection of cell
types, and it is likely that some components ofthe
lung, e.g., the type II granular pneumocytes,
have considerably higher oxygen uptake than the
mean for the whole lung.
Substrate Utilization by Lungs
What are the substrates utilized by the lung for
its metabolic requirements? Although intact
lungs and lung subcellular organelles can oxidize
fatty acids (2, 3), glucose probably serves as the
major oxidizable substrate under usual condi-
tions.-Glucose utilization by the isolated perfused
lung under control conditions is approximately 40
,u mole/hr/g dry weight (4). In the presence of an
inhibitor of oxidative metabolism, the rate of glu-
cose utilization may double indicating a rather
brisk Pasteur effect (5). A similar increase in
glycolytic rate can be found duringperfusion with
an uncoupler of oxidative phosphorylation (D.
Bassett and A. Fisher, unpublished observa-
tions). The fate of the carbons from glucose
metabolized by an isolated lung preparation is
shown in Figure 1. In this and many similar
studies in the literature, approximately half of
the glucose was converted to lactate and pyr-
uvate. The "reason" for the high rate of produc-
FIGURE 1. Recovery of carbon atoms derived from glucose in
various products of metabolism during perfusion of the
isolated ratlungwith 5.5mM [U-14C] glucose in Krebs-Ringer
bicarbonate solution, pH 7.4, containing 3% bovine serum
albumin. Lactate and pyruvate were recovered in the per-
fusate, "4CO2 was recovered in the perfusate plus ventilatory
gas, and the other components were recovered in tissue ex-
tracts. The data arerepresented as 0/0 oftotal recovery.
tion of these three-carbon compounds has not
been defined. One postulated explanation relates
to the presence of numerous cells in the lung with
relatively sparse mitochondria and, therefore,
limited citric acid cycle activity. Additional
possibilities include limited activity of mitochon-
drial H shuttle mechanisms or mitochondrial
pyruvate dehydrogenase. In any case, the high
lactate production under control conditions was
probably not due to cellular hypoxia since the
lung was being ventilated with 95% 02, the per-
fusate L/P ratio was within a normal range (i.e.,
5-10), and the lung responded briskly to inhibi-
tors of oxidative metabolism with change in re-
dox state (5). Approximately one fourth of the
glucose carbons utilized by the perfused lungs are
oxidized to C02. In our experiments, about 25%
of this C02 is derived from the pentose shunt
pathway and the remainder from mitochondrial
oxidation (D. Bassett and A. Fisher, unpublished
observations). There are also active pathways for
incorporation of glucose carbons into tissue com-
ponents including proteins, nucleic acids, poly-
saccharides (chiefly glycogen), and other uniden-
tified components. Finally, a small but significant
fraction of glucose carbons is used for synthesis
of lipids, including the fatty acid as well as glyc-
eride-glycerol moieties.
Energy Storesofthe Lung
The next question to explore is whether oxi-
dative metabolism is required in order to main-
tain normal energy stores of the lung tissue. In-
sight into this problem can be obtained by meas-
urement ofchanges in lung tissue adenine nucleo-
tide content during inhibition of oxidative me-
tabolism, or uncoupling of oxidative phosphoryla-
tion. During control perfusion, ATP content of
the lung per unit weight is comparable to values
observed in other aerobic tissues and the ATP/
ADP ratio is approximately 8.5 (Fig. 2). During
inhibition of oxidative metabolism with carbon
monoxide ventilation, there is a marked decrease
in the lung ATP content as well as decreases in
the ATP/ADP ratio. During perfusion with dini-
trophenol, an uncoupler of oxidative phosphory-
lation, lung ATP content and ATP/ADP ratio
also decrease, although the change is less marked
than with CO ventilation. These results indicate
that oxidative metabolism is required in order to
maintain normal lung tissue energy stores and
suggest that energy-dependent metabolic proc-
esses will be depressed subsequent to inhibition
ofoxidative metabolism.
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FIGURE 2. ATP content and ATP/ADP in isolated perfused rat
lungs under control conditions and during ventilation with
95% C0:5% C02 (C0) or perfusion with 0.8mM
dinitrophenol (DNP). At the end of 60-90 min of perfusion,
lungs were rapidly frozen at the temperature of liquid N2,
extracted with cold ethanolic perchloric acid, and assayed for
adenine nucleotide content by enzyme methods (5).
Energy-Dependent Lung
Functions
What are the metabolic processes in the lung
that are energy-dependent? Certainly the lung
has no physiologic process that requires large ex-
penditures of energy such as occurs with cardiac
muscle contraction, renal transport, or mainte-
nance of ionic gradients in nerve tissue. Energy
utilization, however, is required for functioning
of several lung systems. For example, lung clear-
ance depends on bronchial ciliary activity and
phagocytosis by alveolar macrophages, both of
which are energy dependent. During anoxia,
there is cessation of ciliary beating (6) and inhibi-
tion of particle phagocytosis (7). Secretion by
bronchial glands and constriction of tracheobron-
chial smooth muscle are other processes that pre-
sumably are energy-dependent. Synthesis of di-
palmitoyl lecithin, a major component of the lung
surfactant system, requires a supply of ATP (8).
The actual secretion ofsurfactant is also probably
an energy-requiring process analogous to cellular
secretion elsewhere. Finally, energy is required
for cell transport processes, including those that
maintain the cellular internal milieu and provide
substrate as well as specialized transport func-
tions such as the active uptake of 5-HT (see
below). Recognition of these energy-dependent
physiologic parameters suggest that some lung
functions might be impaired in the absence of ox-
idative metabolism.
Lung Surfactant
The most dramatic metabolic function of the
lung and the one that has been studied to the
greatest extent relates to the synthesis of lung
surfactant. The lung surfactant is contained in
the extracellular alveolar lining layer that coats
the epithelial surface of the lung alveoli. The
presumed physiologic function of the surfactant
system is to maintain the surface tension at the
interface between the alveolar surface and the air
spaces at low levels and thereby promote alveolar
stability. The extracellular material can be ob-
tained for study by alveolar lavage with saline or
other physiologic solution. The material so ob-
tained contains approximately 75°/ phospholip-
ids, 15% neutral lipids, and 10% protein (9).
Dipalmitoyl lecithin (dipalmitoyl phosphatidyl-
choline) accounts for approximately 40% of the
total solids in the surfactant fraction. Synthetic
dipalmitoyl lecithin (DPL) manifests similar sur-
face active properties to the crude surfactant
fraction so that the physiologic properties of the
surfactant are thought to be related chiefly to the
presence of DPL. An additional 25% of the sur-
factant material is comprised of lecithins contain-
ing unsaturated fatty acids. The physiologic role
of this fraction of the surfactant is not known but
may be important as an aid to spreading or other-
wise influencing dispersion of the dipalmitoyl
lecithin fraction. The role of the protein in surfac-
tant is also incompletely understood. Current
evidence suggests that the protein is specific to
the lung and that surfactant is secreted as a
lipoprotein complex.
Surfactant Synthesis and Turnover
What is the source of surfactant and what are
the pathways involved in its production? It now
seems clear that surfactant is synthesized in the
lung and subsequently secreted onto the alveolar
surface. Most studies that have investigated sur-
factant production have focused on pathways of
dipalmitoyl lecithin synthesis although, as noted
above, DPL is only one component of the surfac-
tant fraction. These studies have shown that DPL
is synthesized chiefly by the classical pathway in-
volving phosphatidic acid (formed from glycerol-
3-phosphate and palmitate) and CDP-choline
(formed from CTP and choline). Considerable ef-
fort is currently being directed to determine the
factors that are important in control of this path-
way in the lung.
Interesting insight into the overall importance
of surfactant synthesis to lung economy has been
August 1976 5obtained by analysis ofthe relative proportions of
the various fatty acids in lung tissue. Compared
with other organs, such as the brain, liver, and
kidney, lungs from a variety of species have an
unusually high proportion of palmitate in relation
to other saturated or unsaturated fatty acids (10).
Therefore, lung tissue appears to be geared
towards utilization of palmitate and subsequent
synthesis of dipalmitoyl lecithin. Extraction of
free fatty acids from the blood supply is one likely
source of the palmitate that is required for DPL
synthesis. Significant uptake of palmitate into
the lung was noted within 5 min after injection of
tritiated palmitate into rats (11). By auto-
radiography, most of the label was found in
type II alveolar cells (11), which therefore, seem
to be most active in accumulating fatty acids from
the circulation. In addition to uptake from the
free fatty acid fraction, palmitate may also be
derived from circulating lipoproteins. This source
is possible, since lung endothelium is rich in
heparin-activated lipoprotein lipase (12), which
can hydrolyze lipoproteins into constituent fatty
acids thereby creating a potential fatty acid res-
ervoir for lung uptake. In addition to uptake of
fatty acids from the vascular space, fatty acids
can be synthesized intracellularly de novo from
two-carbon precursors derived from glucose (see
above), although this pathway is probably not
sufficient to supply totally the fatty acid re-
quirements of the lung. The factors controlling
the relative role for each of these sources of
palmitate have not been determined.
The metabolic requirements for palmitate are a
function of the turnover rate for this moiety in
the synthesis of surfactant. Following injection of
C14 palmitate in vivo, radioactivity accumulates
in lung tissue and reaches peak values in about 1
hr, followed by a gradual decline of radioactivity
with half-time of approximately 12 hr (13). The
appearance of radioactivity in alveolar lavage
material is delayed relative to lung tissue (peak
values are reached after approximately 6 hr), but
declines at a similar rate as observed in lung tis-
sue (13). These results suggest movement of
palmitate from tissue to alveolar space with a rel-
atively rapid turnover. Turnover time for other
portions of surfactant material may be slightly
longer, suggesting that some components are re-
cycled, but the general conclusion is that syn-'
thetic activity for all components of the surfac-
tant system is an active process requiring contin-
uing metabolic activity.
Based on experiments of the type summarized
above, the current concept is that surfactant syn-
thesis is a major metabolic activity of the lung.
Substrates for surfactant synthesis are trans-
ferred from the circulation or alveolar space to
type II epithelial cells where the lipid and protein
components are synthesized, presumably in the
endoplasmic reticulum and Golgi organelles.
These components are then packaged in lamellar
bodies for storage and subsequently released on-
to the alveolar surface. Considerable work re-
mains in order to define factors controlling syn-
thesis, release, and turnover ofsurfactant.
Disorders ofSurfactant Synthesis
Shortly after appreciation of the importance of
surfactant in respiratory physiology, surfactant
deficiency was found in lungs of infants with
respiratory distress syndrome (RDS). Investiga-
tions into possible mechanisms have resulted in
increased understanding of the development and
maturation of the surfactant system. One key
finding is that the lung surfactant system ma-
tures relatively late in the course of fetal de-
velopment. In the monkey (gestation period 170
days), significant amounts of lecithin are not
present in the alveolar lining material until gesta-
tion is approximately 80% complete (14). Ap-
pearance of lecithin on the alveolar surface cor-
relates with a sharp increase of lecithin in the
lung hemogenate and the presence of lamellar
bodies in the type II alveolar cells. Since res-
piratory distress syndrome in the newborn is
associated with prematurity, the concept has
arisen that RDS represents birth of the fetus
before complete maturation of the lung surfac-
tant system. Recently, several groups have in-
vestigated potential mechanisms to accelerate
the normal rate of maturation of the surfactant
system. One promising method is administration
of adrenocorticosteroid hormones which do ap-
pear to accelerate maturation and protect infants
delivered prematurely against development of
RDA (15). Several of the enzymes in the path-
ways of phospholipid synthesis undergo induc-
tion with steroid treatment which might account
for the accelerated maturation (10). This area is
under active investigation at the moment and
promises great potential benefit in terms of the
prevention ofa common cause ofinfant mortality.
Metabolism of Hormones and
Xenobiotics
The discussion up to this point has been con-
cerned with intrinsic metabolism of the lung in
order to maintain its structure and function.
Environmental Health Perspectives 6Another important role for the lung that has
recently been extensively investigated is con-
cerned with the metabolism of xenobiotics and
endogenous hormones. Through these pathways,
the lungs are able to exert a major influence on
bodily homeostasis. As one example of hormone
metabolism, lungs rapidly clear serotonin (5-HT)
from blood or other media perfusing the pulmo-
nary circulation (17, 18). This amine can be taken
up against a concentration gradient by a mech-
anism that shows saturation kinetics, is depend-
ent on external sodium, and can be blocked by
specific competitive inhibitors, inhibitors of ox-
idative metabolism, and by ouabain (Fig. 3).
After uptake, serotonin is metabolized by a
monoamine oxidase (MAO) to 5-hydroxy-indole-
acetic acid. The rate of metabolism does not
significantly influence the rate of uptake. These
characteristics suggest that uptake of serotonin
by the lung occurs by active transport and that
transport is the rate limiting step in serotonin
clearance. Autoradiographic studies have demon-
strated that the transport process occurs almost
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FIGURE 3. Disappearance of serotonin from the perfusate dur-
ing perfusion of the isolated guinea piglung. The concentra-
tion of serotonin in perfusate is plotted as a logarithmic
function of time. Note the marked depression of serotonin
uptake in the presence of O.1mM imipramine (a competitive
inhibitor of amine transport), lmM KCN (an inhibitor of
oxidative metabolism), lmM sodium iodoacetate (an inhi-
bitor of glycolysis), and 0.01mM ouabain (an inhibitor of
Na+-K+-activated ATPase).
exclusively into the pulmonary endothelium (19).
The mechanism for amine transport shows speci-
ficity, since histamine, another vasoactive com-
pound, is not taken up nor metabolized by lung to
any significant extent. As another example of
specificity, norepinephrine is taken up and me-
tabolized whereas epinephrine is not.
Uptake and metabolism is only one mechanism
by which the lung transforms vasoactive com-
pounds. An additional pattern is operative with
respect to conversion of angiotensin I to angio-
tensin II (resulting in formation of a potent
vasoactive compound) or hydrolysis of peptide
bonds in brandykinin (resulting in a loss of
biological activity). The responsible peptidase en-
zyme (converting enzyme) is either the same for
both reactions or represents a group of closely
related enzymes. Converting enzyme activity is
present on the luminal surface of the pulmonary
endothelium (20), so that hydrolysis occurs at the
membrane surface and active transport into the
cell is not required. A more complex relationship
can be seen with several of the prostaglandins
since the lung is an important site for uptake and
metabolism as well as synthesis, storage, and
release (21).
In addition to contact with endogenous agents,
the lung is exposed to a wide variety ofpotential-
ly toxic substances delivered either through in-
halation or via the circulation. A major pathway
for detoxification of foreign components such as
drugs is through hydroxylation in the liver by cy-
tochrome P-450-linked reactions. Recently, this
pathway has also been demonstrated in isolated
lung microsomes. These organelles from lung con-
tain, on a weight basis, approximately 25% ofthe
cytochrome P-450 activity ofmicrosomes isolated
from liver (22). More recently, we have
demonstrated cytochrome P-450-linked activity
in the isolated perfused rabbit and rat lung (23).
The reaction studied in these experiments was
the demethylation and hydroxylation of p-
nitroanisole to p-nitrophenol which requires
NADPH, molecular oxygen, and cytochrome P-
450. Production of p-nitrophenol during infu-
sion ofp-nitroanisole was indicated by increased
optical density (Fig. 4). Production could be
reversibly blocked by ventilation with 80% car-
bon monoxide due to binding between CO and cy-
tochrome P-450. The significance of this reaction
in the lung has not been fully explored but may be
important in the local detoxification of drugs,
possibly explaining vagaries of drug activity on
the lung. It has also been suggested that this
pathway may be responsible for the local conver-
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FIGURE 4. Demonstration of cytochrome P-450 activity in the
isolated perfused rabbit lung. Lungs were perfused with a
"once-through" system. The effluent was sampled continu-
ously, and optical density (A) was monitored at 436 nm with
a flowthrough cuvette. The start ofp-nitroanisole infusion is
indicated at the bottom of the figure. The increase in optical
density indicates production of p-nitrophenol via a
cytochrome P-450-linked reaction. The reaction is reversibly
inhibited by ventilation of the lung with 75%0/ C0:20% 02:
5% CO2 (indicated by CO).
sion of nontoxic compounds into carcinogenic
agents.
Response of Lungto Oxidants
Is this role of the lung in the metabolism of
vasoactive compounds and xenobiotics altered in
the presence of lung disease? It seems likely that
alteration of some of these important metabolic
functions does occur, although investigations are
in the preliminary stages. One area ofextreme in-
terest related to lung pathophysiology involves
the response ofthelung to oxidants, including the
pollutants ozone and nitrogen dioxide as well as
therapeutically administered oxygen in high con-
centrations. As an interesting metabolic correla-
tion, activity of several enzymes, specifically
those concerned with the pentose shunt pathway
and dismutation of the superoxide anion, may be
involved in protection of the lung against oxidant
damage (24). Recently, we have found that
serotonin uptake by the isolated perfused lung is
diminished by exposure to oxygen (25), and we
have interpreted these changes as a manifesta-
tion of early pulmonary oxygen toxicity. In nor-
mal rats exposed to 100% oxygen at one atmos-
phere, approximately 20% depression of seroton-
in clearance was noted after 18 hr of exposure.
This toxic effect of 02 was greatly magnified in
animals maintained on a vitamin E-deficient diet
for 4-6 weeks. In these vitamin E-deficient ani-
mals, serotonin uptake was depressed approxi-
mately 50% after 12 hr of oxygen exposure. To
put these findings in perspective, pulmonary
functional alterations and electron microscopic
changes are generally not observed in normal
rats until after approximately 24-48 hr of ex-
posure. Therefore, measurement oflung metabol-
ic function, in this case, serotonin uptake, may
provide an early and sensitive index of pulmo-
nary toxicity.
Experiments described in this presentation were carried out
in collaboration with David Bassett, Edward Block, Norio
Itakura, and Harry Steinberg.
REFERENCES
1. Fisher, A. Oxygen utilization and energy production. In:
The Biochemical Basis of Pulmonary Function (Lenfant
Series, Vol. 2), R. G. Crystal, Ed., Marcel Dekker Inc.,
New York, 1975.
2. Rhoades, R. A. Net uptake of glucose, glycerol, and fatty
acids by the isolated perfused rat lung. Am. J. Physiol.
226: 144 (1974).
3. Fisher, A. B., et al. Respiration of rat lung mitochondria
and the influence of Ca2+ on substrate utilization.
Biochemistry 12: 1438 (1973).
4. Weber, K. C., and Visscher, M. B. Metabolism of the
isolated caninelung. Am. J. Physiol. 217: 1044 (1969).
5. Bassett, D. J. P., and Fisher, A. B. Metabolic response to
carbon monoxide by isolated rat lungs. Am. J. Physiol.
230: 658 (1976).
6. Dalhamn, T., Rosengren, A. The effect of oxygen lack on
the tracheal ciliary activity. Arch. Environ. Health 16: 371
(1968).
7. Oren, R., et al. Metabolic patterns in three types of
phagocytizing cells. J. Cell Biol. 17: 487 (1963).
8. Bassett, D.J.P., Fisher, A. B., and Rabinowitz, J. L. Effect
of hypoxia on glucose incorporation into lipids by isolated
rat lung. Am. J. Physiol. 227: 1130 (1974).
9. King, R. J., and Clements, J. A. Surface active materials
from dog lung. II. Composition and physiological correla-
tions. Am. J. Physiol. 223: 715 (1972).
10. Montfoort, A., van Golde, L.M.G., and van Deenen,
L.L.M. Molecular species of lecithins from various animal
tissues. Biochim. Biophys. Acta 231: 335 (1971).
11. Darrah, H. K., and Hedley-Whyte, J. Rapid incorporation
of palmitate into lung: site and metabolic fate. J. Appl.
Physiol. 34: 205 (1973).
12. Hamosh, M. and P. Hamosh. Lipoprotein lipase in rat
lung. The effect of fasting. Biochim. Biophys. Acta 380:
132 (1975).
13. Thomas, T., Jr. and Rhoades, R.A. Incorporation of
palmitate-1-'4C into lung tissue and "alveolar" lecithin.
Am. J. Physiol. 219: 1535 (1970).
14. Morgan, T. E., and Morgan, B. C. Surfactant synthesis,
storage and release by alveolar cells. In: Eds., Respiratory
Distress Syndrome, C.A. Villee, D.B. Villee, and J.
Zuckerman, Eds., Academic Press, New York, pp.
117-125.
15. Howie, R. N., and Liggins, G. C. Prevention ofrespiratory
distress syndrome in premature infants by antepartum
glucocorticoid treatments. In: Respiratory Distress Syn-
drome, C. A. Villee, D. B. Villee, and J. Zuckerman, Eds.,
AcademicPress, New York, pp. 369-380.
16. Farrell, P. M., and Zachman, R. D. Induction of choline
phosphotransferase and lecithin synthesis in the fetal lung
by corticosteroids. Science 179: 297 (1973).
17. Junod, A. F., Uptake, metabolism and efflux of '4C-5-
8 Environmental Health Perspectiveshydroxytryptamine inisolated perfused ratlungs. J. Phar-
macol. Exptl. Therap. 183: 341 (1973).
18. Steinberg, H., Bassett, D.J.P. and Fisher, A. B. Depres-
sion of pulmonary 5-hydroxytryptamine uptake by
metabolic inhibitors. Am. J. Physiol. 228: 1298 (1975).
19. Strum, J. M., and Junod, A. F. Radioautographic
demonstration of 5-hydroxytrypamine-3H uptake by
pulmonary endothelial cells. J. Cell Biol. 54: 456 (1972).
20. Ryan, J. W., et al. Subcellular localization of pulmonary
angiotensin-converting enzyme (kininase II). Biochem. J.
146: 497 (1975).
21. Fanburg, B. L. Prostaglandins and the lung. Am. Rev.
Resp. Dis. 108: 482 (1973).
22. Bend, J.R., et al. A comparative study of the hepatic and
pulmonary microsomal mixed-function oxidase systems in
the rabbit. J. Pharmacol. Exptl. Therap. 183: 206 (1972).
23. Itakura, N., Fisher, A. B., and Thurman, R. Mixed-
function oxidation in isolated, perfused rabbit lungs. Fed.
Proc. 34: 429 (1975); presented at the American
Physiological Society (FASEB) Meeting, Atlantic City,
April 1975.
24. Tierney, D. F. Intermediary metabolism of the lung. Fed.
Proc. 33: 2232 (1974).
25. Block, E. R., and Fisher, A. B. Effect of hyperoxia on 5-
hydroxytryptamine (5-HT) uptake by normal and vitamin
E deficient rat lungs. Clin. Res. 23: 345 (1975); presented
to the American Federation of Clinical Research, Atlantic
City, N. J., May 1975.
August 1976 9